Literature DB >> 32084423

Prevalence and Clinical Features of Inflammatory Bowel Diseases Associated With Monogenic Variants, Identified by Whole-Exome Sequencing in 1000 Children at a Single Center.

Eileen Crowley1, Neil Warner2, Jie Pan2, Sam Khalouei3, Abdul Elkadri4, Karoline Fiedler2, Justin Foong3, Andrei L Turinsky3, Dana Bronte-Tinkew2, Shiqi Zhang2, Jamie Hu2, David Tian2, Dalin Li5, Julie Horowitz6, Iram Siddiqui7, Julia Upton8, Chaim M Roifman8, Peter C Church2, Donna A Wall9, Arun K Ramani3, Daniel Kotlarz10, Christoph Klein10, Holm Uhlig11, Scott B Snapper12, Claudia Gonzaga-Jauregui6, Andrew D Paterson13, Dermot P B McGovern5, Michael Brudno14, Thomas D Walters2, Anne M Griffiths2, Aleixo M Muise15.   

Abstract

BACKGROUND & AIMS: A proportion of infants and young children with inflammatory bowel diseases (IBDs) have subtypes associated with a single gene variant (monogenic IBD). We aimed to determine the prevalence of monogenic disease in a cohort of pediatric patients with IBD.
METHODS: We performed whole-exome sequencing analyses of blood samples from an unselected cohort of 1005 children with IBD, aged 0-18 years (median age at diagnosis, 11.96 years) at a single center in Canada and their family members (2305 samples total). Variants believed to cause IBD were validated using Sanger sequencing. Biopsies from patients were analyzed by immunofluorescence and histochemical analyses.
RESULTS: We identified 40 rare variants associated with 21 monogenic genes among 31 of the 1005 children with IBD (including 5 variants in XIAP, 3 in DOCK8, and 2 each in FOXP3, GUCY2C, and LRBA). These variants occurred in 7.8% of children younger than 6 years and 2.3% of children aged 6-18 years. Of the 17 patients with monogenic Crohn's disease, 35% had abdominal pain, 24% had nonbloody loose stool, 18% had vomiting, 18% had weight loss, and 5% had intermittent bloody loose stool. The 14 patients with monogenic ulcerative colitis or IBD-unclassified received their diagnosis at a younger age, and their most predominant feature was bloody loose stool (78%). Features associated with monogenic IBD, compared to cases of IBD not associated with a single variant, were age of onset younger than 2 years (odds ratio [OR], 6.30; P = .020), family history of autoimmune disease (OR, 5.12; P = .002), extra-intestinal manifestations (OR, 15.36; P < .0001), and surgery (OR, 3.42; P = .042). Seventeen patients had variants in genes that could be corrected with allogeneic hematopoietic stem cell transplantation.
CONCLUSIONS: In whole-exome sequencing analyses of more than 1000 children with IBD at a single center, we found that 3% had rare variants in genes previously associated with pediatric IBD. These were associated with different IBD phenotypes, and 1% of the patients had variants that could be potentially corrected with allogeneic hematopoietic stem cell transplantation. Monogenic IBD is rare, but should be considered in analysis of all patients with pediatric onset of IBD.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Genetics; HSCT; Prevalence; Risk Factor

Mesh:

Substances:

Year:  2020        PMID: 32084423      PMCID: PMC7283012          DOI: 10.1053/j.gastro.2020.02.023

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  60 in total

1.  The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3.

Authors:  C L Bennett; J Christie; F Ramsdell; M E Brunkow; P J Ferguson; L Whitesell; T E Kelly; F T Saulsbury; P F Chance; H D Ochs
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

Review 2.  Ulcerative colitis.

Authors:  Ingrid Ordás; Lars Eckmann; Mark Talamini; Daniel C Baumgart; William J Sandborn
Journal:  Lancet       Date:  2012-08-20       Impact factor: 79.321

Review 3.  Very early onset IBD: novel genetic aetiologies.

Authors:  Vritika Batura; Aleixo M Muise
Journal:  Curr Opin Allergy Clin Immunol       Date:  2018-12

4.  Effect of Genetic Diagnosis on Patients with Previously Undiagnosed Disease.

Authors:  Kimberly Splinter; David R Adams; Carlos A Bacino; Hugo J Bellen; Jonathan A Bernstein; Alys M Cheatle-Jarvela; Christine M Eng; Cecilia Esteves; William A Gahl; Rizwan Hamid; Howard J Jacob; Bijal Kikani; David M Koeller; Isaac S Kohane; Brendan H Lee; Joseph Loscalzo; Xi Luo; Alexa T McCray; Thomas O Metz; John J Mulvihill; Stanley F Nelson; Christina G S Palmer; John A Phillips; Leslie Pick; John H Postlethwait; Chloe Reuter; Vandana Shashi; David A Sweetser; Cynthia J Tifft; Nicole M Walley; Michael F Wangler; Monte Westerfield; Matthew T Wheeler; Anastasia L Wise; Elizabeth A Worthey; Shinya Yamamoto; Euan A Ashley
Journal:  N Engl J Med       Date:  2018-10-10       Impact factor: 91.245

5.  Mutations in Plasmalemma Vesicle Associated Protein Result in Sieving Protein-Losing Enteropathy Characterized by Hypoproteinemia, Hypoalbuminemia, and Hypertriglyceridemia.

Authors:  Abdul Elkadri; Cornelia Thoeni; Sophie J Deharvengt; Ryan Murchie; Conghui Guo; James D Stavropoulos; Christian R Marshall; Paul Wales; Robert Bandsma; Ernest Cutz; Chaim M Roifman; David Chitayat; Yaron Avitzur; Radu V Stan; Aleixo M Muise
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2015-07

6.  Fine-mapping inflammatory bowel disease loci to single-variant resolution.

Authors:  Hailiang Huang; Ming Fang; Luke Jostins; Maša Umićević Mirkov; Gabrielle Boucher; Carl A Anderson; Vibeke Andersen; Isabelle Cleynen; Adrian Cortes; François Crins; Mauro D'Amato; Valérie Deffontaine; Julia Dmitrieva; Elisa Docampo; Mahmoud Elansary; Kyle Kai-How Farh; Andre Franke; Ann-Stephan Gori; Philippe Goyette; Jonas Halfvarson; Talin Haritunians; Jo Knight; Ian C Lawrance; Charlie W Lees; Edouard Louis; Rob Mariman; Theo Meuwissen; Myriam Mni; Yukihide Momozawa; Miles Parkes; Sarah L Spain; Emilie Théâtre; Gosia Trynka; Jack Satsangi; Suzanne van Sommeren; Severine Vermeire; Ramnik J Xavier; Rinse K Weersma; Richard H Duerr; Christopher G Mathew; John D Rioux; Dermot P B McGovern; Judy H Cho; Michel Georges; Mark J Daly; Jeffrey C Barrett
Journal:  Nature       Date:  2017-06-28       Impact factor: 49.962

7.  Trends in Epidemiology of Pediatric Inflammatory Bowel Disease in Canada: Distributed Network Analysis of Multiple Population-Based Provincial Health Administrative Databases.

Authors:  Eric I Benchimol; Charles N Bernstein; Alain Bitton; Matthew W Carroll; Harminder Singh; Anthony R Otley; Maria Vutcovici; Wael El-Matary; Geoffrey C Nguyen; Anne M Griffiths; David R Mack; Kevan Jacobson; Nassim Mojaverian; Divine Tanyingoh; Yunsong Cui; Zoann J Nugent; Janie Coulombe; Laura E Targownik; Jennifer L Jones; Desmond Leddin; Sanjay K Murthy; Gilaad G Kaplan
Journal:  Am J Gastroenterol       Date:  2017-04-18       Impact factor: 10.864

8.  Loss of the Arp2/3 complex component ARPC1B causes platelet abnormalities and predisposes to inflammatory disease.

Authors:  Walter H A Kahr; Fred G Pluthero; Abdul Elkadri; Neil Warner; Marko Drobac; Chang Hua Chen; Richard W Lo; Ling Li; Ren Li; Qi Li; Cornelia Thoeni; Jie Pan; Gabriella Leung; Irene Lara-Corrales; Ryan Murchie; Ernest Cutz; Ronald M Laxer; Julia Upton; Chaim M Roifman; Rae S M Yeung; John H Brumell; Aleixo M Muise
Journal:  Nat Commun       Date:  2017-04-03       Impact factor: 14.919

9.  BCFtools/csq: haplotype-aware variant consequences.

Authors:  Petr Danecek; Shane A McCarthy
Journal:  Bioinformatics       Date:  2017-07-01       Impact factor: 6.937

10.  Diagnostic Yield of Next-generation Sequencing in Very Early-onset Inflammatory Bowel Diseases: A Multicentre Study.

Authors:  Fabienne Charbit-Henrion; Marianna Parlato; Sylvain Hanein; Rémi Duclaux-Loras; Jan Nowak; Bernadette Begue; Sabine Rakotobe; Julie Bruneau; Cécile Fourrage; Olivier Alibeu; Frédéric Rieux-Laucat; Eva Lévy; Marie-Claude Stolzenberg; Fabienne Mazerolles; Sylvain Latour; Christelle Lenoir; Alain Fischer; Capucine Picard; Marina Aloi; Jorge Amil Dias; Mongi Ben Hariz; Anne Bourrier; Christian Breuer; Anne Breton; Jiri Bronski; Stephan Buderus; Mara Cananzi; Stéphanie Coopman; Clara Crémilleux; Alain Dabadie; Clémentine Dumant-Forest; Odul Egritas Gurkan; Alexandre Fabre; Aude Fischer; Marta German Diaz; Yago Gonzalez-Lama; Olivier Goulet; Graziella Guariso; Neslihan Gurcan; Matjaz Homan; Jean-Pierre Hugot; Eric Jeziorski; Evi Karanika; Alain Lachaux; Peter Lewindon; Rosa Lima; Fernando Magro; Janos Major; Georgia Malamut; Emmanuel Mas; Istvan Mattyus; Luisa M Mearin; Jan Melek; Victor Manuel Navas-Lopez; Anders Paerregaard; Cecile Pelatan; Bénédicte Pigneur; Isabel Pinto Pais; Julie Rebeuh; Claudio Romano; Nadia Siala; Caterina Strisciuglio; Michela Tempia-Caliera; Patrick Tounian; Dan Turner; Vaidotas Urbonas; Stéphanie Willot; Frank M Ruemmele; Nadine Cerf-Bensussan
Journal:  J Crohns Colitis       Date:  2018-08-29       Impact factor: 9.071

View more
  22 in total

Review 1.  Monogenic inflammatory bowel disease-genetic variants, functional mechanisms and personalised medicine in clinical practice.

Authors:  Aline Azabdaftari; Kelsey D J Jones; Jochen Kammermeier; Holm H Uhlig
Journal:  Hum Genet       Date:  2022-06-28       Impact factor: 4.132

Review 2.  Receptor Guanylyl Cyclase C and Cyclic GMP in Health and Disease: Perspectives and Therapeutic Opportunities.

Authors:  Hari Prasad; John Kandam Kulathu Mathew; Sandhya S Visweswariah
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-29       Impact factor: 6.055

3.  Clinical Phenotypes and Outcomes in Monogenic Versus Non-monogenic Very Early Onset Inflammatory Bowel Disease.

Authors:  Lauren V Collen; David Y Kim; Michael Field; Ibeawuchi Okoroafor; Gwen Saccocia; Sydney Driscoll Whitcomb; Julia Green; Michelle Dao Dong; Jared Barends; Bridget Carey; Madison E Weatherly; Shira Rockowitz; Piotr Sliz; Enju Liu; Alal Eran; Leslie Grushkin-Lerner; Athos Bousvaros; Aleixo M Muise; Christoph Klein; Vanessa Mitsialis; Jodie Ouahed; Scott B Snapper
Journal:  J Crohns Colitis       Date:  2022-09-08       Impact factor: 10.020

Review 4.  A Systematic Review of Monogenic Inflammatory Bowel Disease.

Authors:  Ryusuke Nambu; Neil Warner; Daniel J Mulder; Daniel Kotlarz; Dermot P B McGovern; Judy Cho; Christoph Klein; Scott B Snapper; Anne M Griffiths; Itaru Iwama; Aleixo M Muise
Journal:  Clin Gastroenterol Hepatol       Date:  2021-03-18       Impact factor: 11.382

Review 5.  Comprehensive comparison between 222 CTLA-4 haploinsufficiency and 212 LRBA deficiency patients: a systematic review.

Authors:  M Jamee; S Hosseinzadeh; N Sharifinejad; M Zaki-Dizaji; M Matloubi; M Hasani; S Baris; M Alsabbagh; B Lo; G Azizi
Journal:  Clin Exp Immunol       Date:  2021-05-03       Impact factor: 5.732

6.  Clinical Genomics for the Diagnosis of Monogenic Forms of Inflammatory Bowel Disease: A Position Paper From the Paediatric IBD Porto Group of European Society of Paediatric Gastroenterology, Hepatology and Nutrition.

Authors:  Holm H Uhlig; Fabienne Charbit-Henrion; Daniel Kotlarz; Dror S Shouval; Tobias Schwerd; Caterina Strisciuglio; Lissy de Ridder; Johan van Limbergen; Marina Macchi; Scott B Snapper; Frank M Ruemmele; David C Wilson; Simon P L Travis; Anne M Griffiths; Dan Turner; Christoph Klein; Aleixo M Muise; Richard K Russell
Journal:  J Pediatr Gastroenterol Nutr       Date:  2021-03-01       Impact factor: 3.288

7.  Utilization of Whole Exome Sequencing Data to Identify Clinically Relevant Pharmacogenomic Variants in Pediatric Inflammatory Bowel Disease.

Authors:  Daniel J Mulder; Sam Khalouei; Neil Warner; Claudia Gonzaga-Jauregui; Peter C Church; Thomas D Walters; Arun K Ramani; Anne M Griffiths; Iris Cohn; Aleixo M Muise
Journal:  Clin Transl Gastroenterol       Date:  2020-12       Impact factor: 4.396

8.  Human autoinflammatory disease reveals ELF4 as a transcriptional regulator of inflammation.

Authors:  Paul M Tyler; Molly L Bucklin; Mengting Zhao; Timothy J Maher; Andrew J Rice; Weizhen Ji; Neil Warner; Jie Pan; Raffaella Morotti; Paul McCarthy; Anne Griffiths; Annemarie M C van Rossum; Iris H I M Hollink; Virgil A S H Dalm; Jason Catanzaro; Saquib A Lakhani; Aleixo M Muise; Carrie L Lucas
Journal:  Nat Immunol       Date:  2021-07-29       Impact factor: 25.606

9.  Novel CARMIL2 loss-of-function variants are associated with pediatric inflammatory bowel disease.

Authors:  Mara Cananzi; Aleixo M Muise; Luca Bosa; Vritika Batura; Davide Colavito; Karoline Fiedler; Paola Gaio; Conghui Guo; Qi Li; Antonio Marzollo; Claudia Mescoli; Ryusuke Nambu; Jie Pan; Giorgio Perilongo; Neil Warner; Shiqi Zhang; Daniel Kotlarz; Christoph Klein; Scott B Snapper; Thomas D Walters; Alberta Leon; Anne M Griffiths
Journal:  Sci Rep       Date:  2021-03-15       Impact factor: 4.379

Review 10.  Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management.

Authors:  Gerhard Rogler; Abha Singh; Arthur Kavanaugh; David T Rubin
Journal:  Gastroenterology       Date:  2021-08-03       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.